|
| | 
|
 | |
        
|  |
 
|
| PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Pfizer Static Chart |
 Pfizer - [Ticker: PFE] |     | | Last Trade | 45.14 | Last Trade Time | 2018-12-04 - 00:00:00 | | Variation | --0.85 (+0.98%) | Open | 46.23 | | High | 46.47 | Low | 45.11 | | Volume | 26,062,310 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 35.33 x 5,700 - 35.34 x 8,100 | | Former Close | 45.99 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
|
News about Pfizer [PFE]: (ordered by relevance)
| - Pfizer CEO confident Covid treatment pill will be effective against omicron variant CNBC
- Pfizer CEO: We?re working on vaccine for Omicron; our pill will also be effective The Times of Israel
- From Pfizer to Moderna: What vaccine makers are saying about omicron jabs Hindustan Times
- Pfizer's Pill, Shot Push Stock to Record as Variant Emerges Bloomberg
- Moderna, Pfizer, J&J talk omicron response Fox Business
- Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17 CNN
- FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds The Wall Street Journal
- Pfizer set to request authorization for coronavirus booster for 16- and 17-year-olds The Washington Post
- Pfizer Reportedly Plans To Ask For Approval Of Covid Boosters For 16- And 17-Year-Olds Forbes
- U.S. FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds - WSJ Reuters
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study Pfizer
Pfizer now expects to produce 80 mln courses of COVID-19 pill, CEO tells CNBC Reuters
Fact check: New ingredient in Pfizer COVID-19 vaccine mischaracterized in online posts USA TODAY
Pfizer Is Lobbying to Thwart Whistleblowers Exposing Fraud The Intercept
Balance of Power: Pfizer CEO on Omicron Vaccine (Radio) Bloomberg
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age Pfizer
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATYŽ in Children 5 to Pfizer
Pfizer CEO on Omicron Covid-19 Variant, Vaccine Supply Bloomberg
Omicron: All UK adults to get Pfizer or Moderna booster Proactive Investors UK
Investing in Pfizer Stock (PFE) Investopedia
Wall Street Covid Fears Ease, Retail Outlook, Pfizer Bloomberg
Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week Motley Fool
Will Pfizer Stock Continue To Rise? Forbes
Pfizer expects to produce 80 mln courses of COVID-19 antiviral pill The Jerusalem Post
Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021 The Guardian
Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine FiercePharma
Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation BioSpace
Omicron: Pfizer, BioNTech and Moderna race to tweak Covid vaccines against new Coronavirus variant City A.M.
Pfizer and BioNTech Receive Expanded US FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older Pfizer
234,000 doses of Pfizer vaccine released following intensive testing The Libya Observer
S. Africa Wants J&J, Pfizer Vaccine Delivery Delay, News24 Says Bloomberg
Egypt authorizes Pfizer's COVID-19 vaccine for 12 to 15 year-olds Reuters
Moderna, Pfizer, and Adagio likely to benefit from Omicron variant - Morgan Stanley Seeking Alpha
Covid-19: New research reveals Pfizer is making misleading claims about fair distribution of vaccines Amnesty International
Coronavirus: Pfizer jabs for 5-11 years old by December 20 Cyprus Mail
New Kent County High School to hold Pfizer COVID-19 vaccine clinic for children ages 5-11 WWBT NBC12 News
Why Pfizer Rose While the Market Sank on Wednesday Motley Fool
Pfizer marks World Antimicrobial Awareness Week P.M. News
Pfizer Covid Vaccine Generated Most Antibodies in Comparative Study Bloomberg
CDC backs Pfizer Covid-19 vaccine for young children The Guardian
Thinking about trading options or stock in Pfizer, American Airlines, Krystal Biotech, NVIDIA, or Alibaba? PRNewswire
Exact Sciences ends co-promotion deal with Pfizer for Cologuard Seeking Alpha
Pfizer: Bull vs. Bear Motley Fool
Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana Pfizer
Stocks making the biggest moves in the premarket: Pfizer, Under Armour, Generac and more CNBC
Pfizer Vaccine Supplies Dwindle in Germany The New York Times
S.Korea to purchase 70000 courses of new Pfizer COVID-19 pill Reuters
Pre-Market Most Active for Nov 29, 2021 : NRXP, SQQQ, PFE, CCL, MRNA, AAPL, LI, AAL, RLX, NIO, NCLH, F Nasdaq
MRNA, PFE, BNTX, FSR, NVAX: Which Stocks are Trending Today 29 Nov? Value The Markets
Covid-19 vaccine: UAE announces Pfizer, Sputnik booster shots for all eligible adults Khaleej Times
Germany recommends only Biontech/Pfizer vaccine for under-30s Reuters
High Doses Of Dividend Growth Expected From Pfizer, Eli Lilly, Bristol Myers In December Seeking Alpha
Rutgers Expanding Enrollment for Pfizer COVID-19 Pediatric Vaccine Trial TAPinto.net
Pfizer board member Gottlieb says the Covid pandemic could be over in the U.S. by January CNBC
An Intrinsic Calculation For Pfizer Inc. (NYSE:PFE) Suggests It's 50% Undervalued Nasdaq
Bitcoin reverses ?bear market? at $53.5K as Pfizer gains on fresh panic over coronavirus ?Nu? variant Cointelegraph
Strength of COVID-19 antibodies depends on age and sex, study finds Daily Mail
Health Care District of Palm Beach County continues to offer Pfizer vaccines across school district WPBF West Palm Beach
President Biden Says Medical Team Believes Vaccines Provide Protection; Says Team Is Working With Moderna, Pfizer On Contingency Plan Benzinga
Pfizer gene therapy research delayed by trial changes, safety questions BioPharma Dive
Covid News: Los Angeles Businesses Grapple With Vaccine Mandate The New York Times
Pfizer Stock Active After CFO Retirement, FDA Application For COVID Pill Approval TheStreet
Covid Updates: Pfizer Says Its Antiviral Pill Is Highly Effective The New York Times
Covid News: D.C. Eases Indoor Mask Restrictions The New York Times
Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine News-Medical.net
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age | NEJM nejm.org
Elizabeth Holmes cross-examination: 'The devil will be in the details' Yahoo Finance
FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and older CNN
Here?s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month Forbes
Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years Pfizer
Pfizer-BioNTech COVID-19 Vaccine COMIRNATYŽ Receives Full US FDA Approval for Individuals 16 Years and Older Pfizer
Pfizer accused of holding Brazil ?to ransom? over vaccine contract demands The Guardian
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study Pfizer
Freedom of Information request on REG 174 for Pfizer COVID-19 mRNA vaccine (FOI 21-611) GOV.UK
Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month CNBC
Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs The Guardian
Pfizer Covid jab ?90% effective against hospitalisation for at least 6 months? The Guardian
Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared Pfizer
Pfizer and BioNTech Announce Submission of Initial Data to US FDA to Support Booster Dose of COVID-19 Vaccine Pfizer
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study Pfizer
First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose GOV.UK
Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports The BMJ
Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech GOV.UK
Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial NPR
FactCheck: what are the safety risks of the Pfizer vaccine? Channel 4 News
Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech GOV.UK
Pfizer/BioNTech COVID-19 vaccine shelf-life extended from 5 to 31 days, says MHRA GOV.UK
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the US FDA Pfizer
Pfizer and BioNTech Expand Collaboration with US to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries Pfizer
Pfizer and BioNTech Announce Collaboration With Brazil's Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America Pfizer
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults Pfizer
Pfizer raises sales forecast for Covid vaccine by almost a third to $33bn Financial Times
Covid-19: FDA set to grant full approval to Pfizer vaccine without public discussion of data The BMJ
Pfizer CEO says third Covid vaccine dose likely needed within 12 months CNBC
Australia shores up Pfizer supply after days of uncertainty The Guardian
Pfizer to Acquire Trillium Therapeutics Inc. Pfizer
Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for US FDA Approval of Their COVID 19 Vaccine Pfizer
Pfizer vaccine effectiveness declines faster than AstraZeneca ? study Evening Standard
Pfizer and Moderna investors brace for eventual drop in vaccine sales Financial Times
Is Pfizer Stock Set To See Higher Levels Post Q2 Results? Forbes
MHRA statement on booster doses of Pfizer and AstraZeneca COVID-19 vaccines GOV.UK
Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month Nasdaq
Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it's not contamination FiercePharma
Boys more at risk from Pfizer jab side-effect than Covid, suggests study The Guardian
Pfizer Declares Fourth-Quarter 2021 Dividend Pfizer
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants Pfizer
Pfizer (PFE) Shot's Protection Against Hospitalization Wanes in Study Bloomberg
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV) Pfizer
| For more news about Pfizer click here:
Pfizer News |
|
Website Width:
Background image: |
|  | |
|
|
